BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2013
View Archived Issues
Astellas Pharma reflects on achievements of fiscal 2012
Read More
Genentech describes novel mTOR inhibitor, GNE-555
Read More
Researchers identify novel urine biomarkers of renal allograft rejection
Read More
In vivo efficacy and lower risk of adverse events seen in models of IPF
Read More
Erythropoietin as a biomarker of childhood asthma
Read More
Zalicus Pharmaceuticals presents in vivo data for novel calcium channel blockers
Read More
Enrollment completed in phase IIb study of Pexa-Vec for hepatocellular carcinoma
Read More
AcelRx reports on final phase III study of Sufentanil NanoTab PCA System
Read More
First stage of Oncolytics Biotech's phase II metastatic melanoma trial meets endpoint
Read More
Salix Pharmaceuticals reports data for budesonide foam in ulcerative proctitis
Read More
Empire Genomics licenses novel DNA biomarker for neuroendocrine prostate cancer
Read More
Perosphere cleared for study of PER-977 to reverse anticoagulant activity
Read More
Growth hormone as a potential biomarker of efficacy for phase I of ADX-71441
Read More
ST2 biomarker may predict organ rejection in heart transplant patients
Read More
Corgenix forms diagnostic development agreement with Lilly
Read More
uniQure and consortium to receive Eurostars grant to develop RNAi gene therapy
Read More
GlaxoSmithKline receives U.S. government grant to develop new antibiotics
Read More
Enrollment begins in NCI-sponsored trial of Prophage G-200
Read More
Nordion to divest Targeted Therapies business
Read More
Mayo Clinic and Cancer Genetics establish OncoSpire Genomics joint venture
Read More
Roche presents novel GPBAR1 agonists for diabetes
Read More
Scientists at Vereniging VU-Windesheim disclose new H4 receptor ligands
Read More
Novel autotaxin inhibitors reported by Pfizer
Read More
Allergan synthesizes novel protein-tyrosine kinase inhibitors
Read More
A team at Merck & Co. divulges novel ERK-2 inhibitors
Read More
Netherlands first to approve Vesomni
Read More